US Equities Analysis

TECH — Bio-Techne

TECH TECH Price Chart

Bio-Techne (TECH) is a life sciences tools & services company in the Health Care sector. Listed on the NASDAQ, Bio-Techne is a component of the S&P 500 index. As of 2026-06-10, the stock is trading at $52.50.

Key Metrics & Risk

Based on 5-year historical data from Yahoo Finance (daily returns, annualized using 252 trading days).

MetricValue
Latest Price$52.50
Latest Date2026-06-10
Expected Return (Annualized)-7.10%
Risk / Std Dev (Annualized)38.67%
Sharpe Ratio (rf=4.5%)-0.30

S&P 500 Context

  • Sector: Health Care
  • Sub-Industry: Life Sciences Tools & Services
  • Exchange: NASDAQ
  • Index: S&P 500 Component

Risk/Return Profile

The stock shows an annualized expected return of -7.10% with an annualized volatility of 38.67%. The Sharpe ratio of -0.30 (assuming 4.5% risk-free rate) indicates negative risk-adjusted returns relative to the risk-free rate.

Modern Portfolio Theory Positioning

This stock is plotted on the S&P 500 Modern Portfolio Theory chart which visualizes the risk/return trade-off across all S&P 500 components. The chart uses Sharpe ratio as the color dimension, allowing quick identification of stocks with superior risk-adjusted performance.

Fundamentals

MetricValue
Market Cap8.22B
Enterprise Value8.3B
Trailing P/E75.0
Forward P/E25.46
Price to Book4.07
Price to Sales6.79
EV/Revenue6.85
EV/EBITDA22.66

| Profitability | | | Profit Margin | 9.05% | | Operating Margin | 25.19% | | ROE | 5.34% | | ROA | 7.45% |

| Growth | | | Revenue Growth | -1.5% | | Earnings Growth | 128.6% |

| Dividend | | | Dividend Yield | 61.0% | | Payout Ratio | 45.71% | | 5Y Avg Yield | 44.0% |

| Financial Health | | | Total Revenue | 1.21B | | Total Debt | 0.29B | | Total Cash | 0.21B | | Free Cash Flow | 0.3B | | Operating Cash Flow | 0.29B |

| Price & Technical | | | 52W High | $72.16$ | | 52W Low | $43.2$ | | 50-Day Avg | $52.25$ | | 200-Day Avg | $57.5$ | | Beta | 1.36 | | Shares Outstanding | 0.16B | | Float Shares | 0.16B | | Insider Holdings | 0.31% | | Institutional Holdings | 117.91% | | Short Ratio | 4.05 | | Short % of Float | 10.09% |

| Analyst Targets | | | Target High | $75.0$ | | Target Low | $49.0$ | | Target Mean | $61.42$ | | Target Median | $62.0$ | | # of Analysts | 12 | | Recommendation | buy |

Disclaimer

This analysis is for educational purposes only and does not constitute financial advice. Past performance is not indicative of future results. Always conduct your own research or consult a qualified financial advisor before making investment decisions.

us-equity stock equity tech health-care life-sciences-tools--services nasdaq